| Literature DB >> 32214924 |
Guy-Alain Junter1, Laurent Lebrun1.
Abstract
Viral filtration is a critical step in the purification of biologics and in the monitoring of microbiological water quality. Viral filters are also essential protection elements against airborne viral particles. The present review first focuses on cellulose-based filter media currently used for size-exclusion and/or adsorptive filtration of viruses from biopharmaceutical and environmental water samples. Data from spiking studies quantifying the viral filtration performance of cellulosic filters are detailed, i.e., first, the virus reduction capacity of regenerated cellulose hollow fiber filters in the manufacturing process of blood products and, second, the efficiency of virus recovery/concentration from water samples by the viradel (virus adsorption-elution) method using charge modified, electropositive cellulosic filters or conventional electronegative cellulose ester microfilters. Viral analysis of field water samples by the viradel technique is also surveyed. This review then describes cellulose-based filter media used in individual protection equipment against airborne viral pathogens, presenting innovative filtration media with virucidal properties. Some pros and cons of cellulosic viral filters and perspectives for cellulose-based materials in viral filtration are underlined in the review. © Springer Science+Business Media Dordrecht 2017.Entities:
Keywords: Adsorption–elution method; Cellulose filter media; Filtering facepieces; Viral clearance; Virus filtration
Year: 2017 PMID: 32214924 PMCID: PMC7088658 DOI: 10.1007/s11157-017-9434-1
Source DB: PubMed Journal: Rev Environ Sci Biotechnol ISSN: 1569-1705 Impact factor: 8.044
Fig. 1A typical monoclonal antibody recovery process.
Taken from Liu et al. (2010)
Fig. 2The separation spectrum for filtration membranes.
Adapted from Fröhlich et al. (2012)
Fig. 3Schematic representation of the void pore structure of regenerated cellulose hollow fibers used in Planova filters.
Adapted from Makino et al. (1994)
Fig. 4Cross sectional micrograph of Planova (20N model) hollow fiber wall.
Taken from Hongo-Hirasaki (2006)
Virus reduction factors (LRVs) achieved by filtration with Planova filters in the manufacturing process of different blood products (confidence intervals not shown)
| Product | Filtera | Virusb | References | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| B19 V | CPV | PPV | HAV | EMCV | WNV | BVDV | HIV-1 | PRV | |||
| Coagulation factor VIII (cross eight M®) | 35N (DE) | <1.0 | – | – | – | 1.5 | – | >5.3 | – | >4.9 | Furuya et al. ( |
| 20N (DE) | 4.9 | – | >5.1 | >3.4 | >5.8 | – | >4.6 | – | >4.0 | ||
| Coagulation factor VIII (Beriate®) | 20N | – | 3.4 | – | ≥5.5 | – | – | ≥5.8 | ≥6.0 | ≥7.2 | Gröner ( |
| Coagulation factor VIII (Factane®) | 35N + 15N (DE) | – | – | ≥6.1 | ≥3.6 | – | – | ≥4.1 | ≥3.8 | ≥4.9 | Chtourou et al. ( |
| Coagulation factor IX (Replenine®-VF) | 15N (DE) | – | – | – | >6.0 | 5.7 | – | – | >6.6 | – | Roberts et al. ( |
| Human normal immunoglobulin (Nanogam®) | 15N (T)c | >6.1 | >3.4 | – | – | >5.8 | – | >6.3 | >5.4 | >6.1 | Terpstra et al. ( |
| 15N + 15N (T)d | >6.1 | >3.9; ≤4.1 | – | – | >5.8 | – | >6.3 | >5.4 | >6.1 | Koenderman et al. ( | |
| 20N + 20N (DE)d | >4.3; ≤5.1 | >5.8 | >7.2 | >6. | >6.4 | ||||||
| Human intravenous IgG (IVIG) | 35N (DE) | – | – | <1.0 | – | – | – | >4.9 | >5.2 | >4.6 | Dichtelmüller et al. ( |
| C1 esterase inhibitor (C1-INH) (Cetor®) | 15N (DE) | – | >4.5 | – | >4.9 | – | – | >5.5 | >5.6 | >6.4 | Terpstra et al. ( |
| C1-INH | 20N + 15N (DE) | – | ≥7.2 | ≥5.3 | – | – | ≥8.0 | ≥5.3 | ≥5.1 | ≥7.1 | Gröner et al. ( |
| Holotransferrin | 15N + 15N (DE) | – | >6.9 | – | >5.6 | – | – | >7.5 | >6.3 | >6.8 | Koenderman et al. ( |
| Plasma-derived proteinse | 15/20N | – | – | 4.9 | – | 5.3 | ≥5.5 | 4.7 | ≥5.5 | ≥5.3 | Caballero et al. ( |
a DE dead-end (normal) mode, T tangential mode. Filters were associated in series in DE and in parallel in T
bSee Table 2
cFiltration step combined with pepsin treatment at pH 4·4
dExperiments were performed in duplicate; the lowest LRV is given. The filtration step was combined with low pH (4.4) inactivation for enveloped viruses (BVDV, HIV, PRV)
eSeven plasma proteins (and 2 types of Planova filters) were involved (mean LRV values are given)
Main characteristics of viruses used to evaluate the viral clearance efficiency of Planova filters
| Familya | Acronym | Name | Relevantb/model forc | References |
|---|---|---|---|---|
(ssDNA, NE) 18–26 nm | B19 V | Human parvovirus B19 | Relevant | Furuya et al. ( |
| CPV | Canine parvovirus | B19 V | Gröner ( | |
| PPV | Porcine parvovirus | B19 V | Caballero et al. ( | |
(ssRNA, NE) 22–30 nm | HAV | Hepatitis A virus | Relevant | Chtourou et al. ( |
| EMCV | Encephalomyocarditis virus | HAV | Furuya et al. ( | |
(ssRNA, E) 40–60 nm | WNV | West Nile virus | Relevant/HCV | Caballero et al. ( |
| BVDV | Bovine viral diarrhea virus | HCV | Caballero et al. ( | |
(ssRNA, E) 80–120 nm | HIV-1 | Human immunodeficiency virus 1 | Relevant | Caballero et al. ( |
(dsDNA, E) 180–250 nm | SuHV-1 (PRV) | Suid herpes virus 1 (pseudorabies virus) | HSV, CMV | Caballero et al. ( |
ss single stranded, ds double stranded, E enveloped, NE nonenveloped
bKnown to be a frequent contaminant of blood products
c HCV Hepatitis C virus, HSV herpes simplex virus, CMV cytomegalovirus
Virus reduction capacity of the manufacturing process of Beriate®.
Adapted from Gröner (2014)
| Manufacturing process | Virus reduction factors (log10) | ||||
|---|---|---|---|---|---|
| HIV | BVDV | PRV | HAV | Parvovirusa | |
| Pasteurization | ≥6.8 | ≥9.3 | 4.7 | 3.9 | ≥3.8b |
| Ion exchange chromatography | 3.3 | 3.0 | 2.1 | 1.3 | 3.4c |
| 20 N virus filtration | ≥6.0 | ≥5.8 | ≥7.2 | ≥5.5 | 3.4c |
| Overall virus reduction factor | ≥16.1 | ≥18.1 | ≥14.0 | ≥10.7 | ≥10.6 |
aVirus reduction factor demonstrated for
bB19 V (relevant human parvovirus)
cCPV (model virus for B19V)
Studies of the eighties assessing the virus recovery efficiency of viradel concentration methods using electropositive depth filters of cellulosic nature (Zeta Plus™ S Series)
| Filter gradea | Elution bufferb | Secondary concentrationc | Water nature | Virusesh | Recovery yieldj (%) | Concentration factork | References |
|---|---|---|---|---|---|---|---|
| 50S (47 mm) | EB1 (15 ml) | – | Tap waterg (3.8 l) pH adjusted to 7.5 | PV-1 | 56 (±8, | 142 | Sobsey and glass ( |
| 50S (90 mm) | EB2 (72 ml) | – | Tap waterg (9.4–17.5 l) pH adjusted to 7.0–7.5 | MS-2 ØX174/T2/T4 | 89 ( 40 ( | 170 96/80/113 | Goyal et al. ( |
EB2 (60-130 ml) EB2 (30-50 ml) | – | Secondary sewage effluent (5.0–10.0 l) Raw sewage (500 ml) | Indigenous coliphages | 56 ( 57 (±16, | 41 7 | ||
| 60S (142 mm) | EB3, pH 9.0 (75 ml) | Organic flocculationd (×20) | Tap waterg (2 l) pH adjusted to 6.5 Tap waterg (33–64.5 l) pH adjusted to 6.5 | SiRV-A/SA11 | 62 (±16,
47 ( 75 (± 40, 23 (±8,
16 (± 7, | 17 251 400 135 1800 | Guttman-Bass and Armon ( |
30S (47 mm) 30S (142 mm) | EB4 (10 ml) EB4 (50 ml) + EB5 (50 ml) | Hydroextractione (×10) | River water (sewage-polluted) 250 ml 20 l | RV-A | 44 (±6,
16 (±3, | 11 320 | Raphael et al. ( |
60S (273 mm) | EB6 (500 ml) | Hollow fiber ultrafiltration (×14) | Surface water (pond) (65 l) Clarified by prefiltration pH adjusted to 5.5–6.0 Surface water (river) (65 l) | MS-2/PR4 ØX174/T2/P22 Ø6 Indigenous enteric bacteriophages | 93/80 24/87/82 79
50–60 | 121/104 31/113/107 103 929/1114 | Logan et al. ( |
| 30S (273 mm) | EB7 (400 ml) | Inorganicf + organicd flocculation (×330–500) | Activated sludge effluent (19 l) | PV-1 CVB3 |
49 (± 7, 44 ( | 9027 7504 | Chang et al. ( |
| 50S (142 mm) | EB3, pH 9.5 (50 ml) | – | Sewage effluent: - Primary (1 l) - Secondary (5 l/10 l) | Indigenous coliphages | 14 100/50 ( | 3 100 | Rose et al. ( |
| 60S (142 mm) | EB3, pH 9.0 (50–75 ml) | – | Wastewater: - Untreated (300–450 ml) - Primary effluent (550–850 ml) | Indigenous enteroviruses | 24 (±4, 43 (±38, n = 3) | 4 1.4 | Guttman-Bass et al. ( |
aZeta Plus™ S Series depth filters are electropositive filter disks made of a charge-modified cellulose-diatomaceous earth matrix with varying diameters (given in parentheses) and nominal retention ratings: (approximately) 0.6–2.0 μm (30S), 0.4–0.8 μm (50S), 0.2–0.6 μm (60S)
bEB1: 0.05 M glycine–NaOH, pH 11.0; EB2: 1:1 ratio of 1 M NaCl + 8% beef extract, pH 9.0; EB3: 3% beef extract; EB4: 1% tryptose phosphate broth, pH 9.0; EB5: 6% arginine, 6% glycine; EB6: 1% (w/v) beef extract, 0.05 M arginine, pH 9.0; EB7: 4 M urea, 0.05 M lysine, pH 9.0
cFigures in parentheses are volume reduction factors (vol. filter eluate/vol. final viral concentrate)
dObtained by lowering the pH of the protein solution (e.g. beef extract eluent) to 3.5 (Katzenelson et al. 1976)
eDialysis against PEG (Ramia and Sattar 1979)
fPrecipitation with aluminium hydroxide (Wallis and Melnick 1967)
d,e,fSee also APHA, AWWA and WEF Standard Methods for the Examination of Water and Wastewater, 20th edition, 1998, Parts 9510 C (Virus concentration from large sample volumes by adsorption to and elution from microporous filters)g, 9510 D (Virus concentration by aluminum hydroxide adsorption–precipitation)j, and 9510 E (Hydroextraction-dialysis with polyethylene glycol)h
gTap water was dechlorinated by addition of sodium thiosulfate
hCVB3, coxsackievirus B3; PV-1, poliovirus type 1; RV-A, rotavirus A; SiRV-A/SA11, simian rotavirus A/SA11; MS-2, PR4, enterobacteria phages (sex-specific); ØX174, T2, T4, P22, enterobacteria phages (somatic coliphages); Ø6, pseudomonas phage
jAverage values are given (± , standard deviation; n, sample size); combined recovery yields were obtained by combining viradel filtration with a secondary concentration step
kCalculated as (recovery yield) × (volume reduction factor)
Spiking studies assessing the virus recovery efficiency of viradel concentration methods using electropositive microfilters of cellulosic nature (Zeta Plus™ 1 MDS)
| Filter typea | Elution bufferb | Secondary concentrationc | Water nature | Virusesh | Recovery | Concentra-tion factork | References | |
|---|---|---|---|---|---|---|---|---|
| 47-mm disk | EB1, pH 9.5 (5 ml) EB1, pH 9.5 (5 ml) EB2 (5 ml) | – | Pure water (40 ml) Seawater (50 ml) Pure water (1 l) | PV-1 | 50 6 62 | 4 0.6 124 | Katayama et al. (Katayama et al. | |
| 47-mm disk | EB1, pH 9.0 (5 ml) | – | Pure water (500 ml) Tap waterg (500 ml) | PV-1 | 34 ( 15 ( | 34 15 | Haramoto et al. ( | |
| 47-mm disk | EB3, pH 10.0 (100 ml) | Organic flocculationd (×20) Celite adsorption/ elutione (×20) | Tap waterg (100ml) | HAdV-40 HAdV-41 HAdV-40 HAdV-41 |
40 (±10, 23 (±8, 52 (±22, 64 (±4, | 8 1.5 10 13 | McMinn ( | |
| 2 × 90-mm disks | EB4 (n.g.) | PEG precipitationf (n.g.) | Pure water (200 ml) Tap waterg (200 ml) Ground water (200 ml) Surface water (200 ml) Tap waterg (40 l) Ground water (40 l) Surface water (1.9-2.3 l) | Pan-1 Pan-1/PV-1 Pan-1 Pan-1 | 94 ( 73 ( 67 ( 64 (
38 ( 19 ( 14 ( | Huang et al. ( | ||
| 142-mm disk | EB5 (500 ml) | – | Pure water (1 l) | MNV-1 HuNV GII.4 | 54.4 (±8.9, 67.5 (±40.3, | 1 1.4 | Lee et al. ( | |
| 2 × 142-mm disks | EB6 (25 ml) | – | Tap waterg (1 l) | MS-2 ØX174 | 89 (±10, 78 (±17, | 36 31 | Polaczyk et al. ( | |
| Cartridge | EB6 (1 l) | – | Tap waterg (20 l) | MS-2 ØX174 | 32 (±13, 37 (±26, | 6 7 | ||
| Cartridge | EB3, PH 9.0 (2 × 500 ml) | Celite adsorption/elutione (×12.5) | Tap waterg River water | 10 l 100 l 10 l 100 l | PV-1 |
44 (±9, 67 (±6, 30 (±11, 36 (±21, | 55 838 38 450 | Karim et al. ( |
aZeta Plus™ 1 MDS microfilters (pore size: 0.2 μm) are composed of an electropositive, charge-modified, fiberglass and cellulose medium. Flat filter discs are available in varying diameters (e.g. 47 and 142 mm). Cartridges are made of two layers of pleated medium and are available in double open-ended configurations (c. 25-cm length, 0.39-m2 filtration surface)
bEB1: 3% (w/v) beef extract; EB2: 1 mM NaOH, pH 10.5 to 10.8; EB3: 1.5% beef extract, 0.05 M glycine; EB4, 3% beef extract, 0.4 M NaCl, 0.05 M glycine, pH 9.0; EB5: 1.5% beef extract, 0.05 M glycine, 0.01% Tween 80; EB6: 1.5% beef extract, 0.05 M glycine, 0.1% (w/v) sodium polyphosphate, 0.01% (v/v) Tween 80, 0.001% (v/v) Antifoam Y-30 Emulsion, pH 8.0
c,dSee notes to Table 4
eCelite® (Imerys Filtration Minerals, San Jose, CA, USA) diatomaceous earth powder was added to the filter eluent. Viruses adsorbed onto the diatomite particles were released in phosphate buffer (Dahling and Wright 1986)
fAddition of a simple aqueous solution of PEG to the (salt-containing) filter eluate (Lewis and Metcalf 1988; and references therein)
gTap water was dechlorinated by addition of sodium thiosulfate
hHAdV-40, human adenovirus species F, type 40; HAdV-41, human adenovirus species F, type 41; MNV-1, murine norovirus type 1; HuNV GII.4, human norovirus genogroup II; genotype 4; Pan-1, primate calicivirus; PV-1, poliovirus type 1; MS-2, F-RNA coliphage; ØX174, somatic coliphage
j,kSee notes to Table 4
Viral analysis of environmental water samples following virus concentration by the viradel procedure using 1MDS filter cartridges
| Secondary concentrationa | Water nature | Samplesc | Detected virusese | References | ||
|---|---|---|---|---|---|---|
| Vol (l) | No. | >0 | ||||
| OF | Groundwater (private household wells) | 1234 | 194 | 5 | HAV, PV-3, RV-A, NLV GII | Borchardt et al. ( |
| OF or PEGP | Groundwater (municipal drinking-water wells) | 1611 | 48 | 24 | EVsf, RV-A, HAV, NoV GI | Borchardt et al. ( |
| Surface (river) water | 431 | 12 | 10 | EVsf, RV-A, NoV GI | ||
| PEGP | Groundwater (confined aquifer) | 1448 | 30 | 7 | EVsf | Borchardt et al. ( |
| PEGP + CU | Groundwater (irrigation water) | 300 | 29 | 5 | PV-3, HAdVs | Cheong et al. ( |
| Celite A/E | Groundwater (wells and spring in quartz aquifers) | 1570 | 14 | 9 | EVs, ReoVs | Johnson et al. ( |
| (Two cartridges in series) | Drinking water sources (wells, pumps, surface water) | 10 | 541 | 43 | RVs, HAdVs | Verheyen et al. ( |
| OF | Groundwater | 4464 | 5 | 2 | NoV GI/GII | Lee et al. ( |
| Surface water | 186 | 5 | 4 | NoV GI | ||
| OF | Surface water | – | 29 | 27 | EVs, HAstVs, HAdV-40/-41 | Chapron et al. ( |
| OF | Surface (lake) water (source water for drinking water production) | 200 | 204 | 18 | ReoVs | Sedmak et al. ( |
| OF | Surface (lake) water (recreational beach water) | 250–300 | 58 | 14 | HAdVs | Xagoraraki et al. ( |
| OF | Surface (river, lake) water (source water for tap water production) | 200 | 265 | 9 | HAV | Lee et al. ( |
| OF | Wastewater (raw sewage, primary effluent, membrane influent, membrane effluent)b | 20–400 | 32 | 32 | HAdV-A/-C/-F | Kuo et al. ( |
| 32 | 32 | EVs, NoV GII | Simmons et al. ( | |||
| OF | Wastewater (membrane bioreactor effluents) | – | 26 | 21 | HAdVs | Hirani et al. |
| OF | Receiving waters | 120–280 | 125 | 92d | HAdVs, NoVs | Rodriguez et al. Rodríguez et al. |
aOF, organic flocculation; PEGP, polyethylene glycol precipitation; CU, centrifugal ultrafiltration; Celite A/E, Celite adsorption/elution
bWastewater samples taken at different treatment stages of a full-scale municipal membrane bioreactor
cThe average volume, total number and number of virus-positive (for at least one virus type) samples are given
dPositive samples according to total culturable virus assays (HAdVs, 53/125; NoVs, 25/125)
eEV, human enterovirus; HAdV, human adenovirus; HAdV-A/-C/-F, human adenovirus species A/C/F; HAdV-40/-41, human adenovirus species F, type 40/41; HAstV, human astrovirus; HAV, hepatitis A virus; NLV GII, Norwalk-like virus (norovirus) genogroup II; NoV, norovirus; NoV GI/GII, norovirus genogroup I/II; PV-3, human poliovirus type 3; ReoV, reovirus (respiratory enteric orphan virus); RV, rotavirus; RV-A, rotavirus A
fHuman coxsackieviruses, echoviruses (enteric cytopathogenic human orphan viruses) and polioviruses
Spiking studies assessing the virus recovery efficiency of viradel concentration methods by using: electronegative microporous membrane filters of cellulosic nature
| Filter typea Conditioningb | Sample pretreatmentc | Elution bufferd | Secondary concentratione | Water nature | Virusesf | Recovery yieldg (%) | Concentration factork | References |
|---|---|---|---|---|---|---|---|---|
HA (47 mm) Acid rinse | MgCl2 (25 mM) (not for seawater) | EB1 (5 ml) | CU (×5) | Pure water (40 ml) Seawater (50 ml) Artificial seawater (1 l) Seawater (1 l) | PV-1 | 95 89 ( 62 (±10,
67 ( | 8 9 124 670 | Katayama et al. ( |
HA (47 mm) Acid rinse | MgCl2 (25 mM) | EB1 (2.5 ml) | – | Influent wastewater (25 ml) Secondary effluent (250 ml) Final effluent (250 ml) | PV-1 | 23 (±19, 80 (±42, 65 (±28, | 2 80 65 | Katayama et al. ( |
HA (47 mm) Acid rinse | MgCl2 (25 mM) (not for seawater) | EB1 (5 ml) | – | Pure/tap water (500 ml) Secondary effluent (250 ml) Seawater (250 ml) | PV-1 | 83/79 ( 50 (id.) 115 (id.) | 83/79 25 58 | Haramoto et al. ( |
HA Acid rinse | MgCl2 (25 mM), pH adjusted to 5.0 | EB1 (15 ml) | CU (×7.5) | Diluted wastewater (2 l) | RV-A |
3.5 ( | 35 | Fumian et al. ( |
HA (142 mm) Acid rince | MgCl2 (5(1) or 25(2) mM) | EB1 (12 ml) | CU (×6) | (2-l sample volume) Tap water(1) Mineral water(2) Seawater(2) River water(1) | NoV GII/ HAstV-1 |
3/2 ( 23/64 (id.) 5/14 (id.) 18/43 (id.) | 30/20 230/640 50/140 180/430 | Victoria et al. ( |
HA (47 mm) Acid rinse | MgCl2(50 mM), pH adjusted to 3.5 | EB2 (6 ml) | CU (n.g.) | Diluted river water(100 ml) | MS-2/PAdV/ PTV |
6/7/0.5 ( | – | Jones et al. ( |
HA (142 mm) Acid rinse | MgCl2 (50 mM), pH adjusted to 3.5 | EB2 (70 ml) | PEGP (×35) | Pure/river water (1 l) | E-11 NoV GI AdV-5 JCPyV ØX174 |
97/51 ( 90/21 (id.) 88/102 (id.) 25/41 (id.) 6.5/55 (id.) | 485/255 450/106 440/510 123/206 32/275 | Hamza et al. ( |
HA (142 mm) Acid rince | MgCl2(50 mM), pH adjusted to 3.5 | EB2 (70 ml) | PEGP (×35) | Ground/rain/river water (5 l) | MNV-1 MS-2 HAV NoV GI NoV GII RV-A |
22/6/11 ( 5/6/3 (id.) 32/30/21.5 (id.) 24/13/8 (id.) 27.5/20/14 (id.) 10/1/0 (id.) | 548/145/268 128/140/85 803/750/538 598/330/208 688/495/345 245/33/0 | Keuckelaere et al. (de Keuckelaere et al. |
| HA (47 mm) | MgCl2 (25 mM) | EB3 (5 ml) | – | Pure/tap water (500 ml) | PV-1 | 55/23 ( | 55/23 | Haramoto et al.( |
| GS (47 mm) | MgCl2 (50 mM) | EB4 (6 ml) | CU (n.g.) | Diluted river water (100 ml) | MS-2/PAdV/ PTV |
52/95/1.5 ( | – | Jones et al. ( |
| SC (47 mm) | pH adjusted to 3.5 | EB5 (4 ml) | CU (×20) or evaporation (×20) | Source water (1 l) | HAdV-41 | 55 (±19)
19 (CU)/48 | – | Wu et al. ( |
HA (47 mm) Acid rinse | AlCl3 (5 mM) (not for seawater), pH adjusted to 3.5 | EB1 (10 ml) | CU (×50) | Desalinated seawater (1 l) Seawater (1 l) Secondary effluent (200 ml) | rAdV-5 |
66 (±14, 49 (±19, n≥3) 28 (±13, n ≥ 3) | 3300 2450 280 | Li et al. ( |
HA (47 mm) AlCl3 Acid rinse | – | EB1 (5 ml) | – | Pure/tap water 500 ml 1 l 10 l | PV-1 | 88/82 ( 98/99 ( 109 ( | 88/82 196/198 2180 | Haramoto et al. ( |
aMillipore mixed cellulose ester membranes; pore sizes: 0. 22 μm (GS); 0.45 μm (HA), 8.0 μm (SC). Filter diameters are given in parentheses
bAcid rinse: filter rince with 0.5 mM H2SO4, pH 3.0 before virus elution; AlCl3: a solution of AlCl3 (250 mM) was passed through the filter before sample filtration
cMgCl2 or AlCl3: a solution of MgCl2 or AlCl3 was added to the water sample before filtration. Tap water was dechlorinated by addition of sodium thiosulfate
dEB1: 1 mM NaOH, pH 10.8; EB2, 50 mM KH2PO4, 1.0 M NaCl, 0.1% (v/v) Triton X-100, pH 9.2; EB3, 3% (w/v) beef extract, pH 9.0; EB4, 3% beef extract, 0.5 M NaCl, pH 9.0; EB5, 1.5% beef extract, 0.75% glycerol, pH 9.0
eCU, centrifugal ultrafiltration (using centrifugal filter units); PEGP, polyethylene glycol precipitation (Lewis and Metcalf 1988). Figures in parentheses are volume reduction factors (vol. filter eluate/vol. final viral concentrate)
f(r)AdV-5, (recombinant) adenovirus type 5 vector; E-11, human echovirus (enteric cytopathogenic human orphan virus) type 11; HAdV-40, human adenovirus species F, type 40; HAdV-41, human adenovirus species F, type 41; HAstV-1, human astrovirus type 1; HAV, hepatitis A virus; JCPyV, JC human polyomavirus; MNV-1, murine norovirus type 1; MS-2, F-RNA coliphage; NoV GI, norovirus genogroup I; NoV GII, norovirus genogroup II; PAdV, porcine adenovirus; PV-1, human poliovirus type 1; PTV, porcine teschovirus; RV-A, rotavirus A; ØX174, somatic coliphage
gAverage values are given (±, standard deviation; n, sample size); combined (recovery yields), obtained by combining viradel filtration with a secondary concentration step
hWater samples were spiked with a mixture of 3 viruses that were eluted together
iWater samples were spiked with a mixture of 5 viruses that were eluted together. Median recovery values are given
jObtained by multiplying the recovery yields of the two concentration steps evaluated separately
kCalculated as (recovery yield) × (volume reduction factor)
Viral analysis of environmental water samples following virus concentration by the viradel procedure using Millipore HA mixed cellulose ester membrane filters
| Methoda | Water nature | Samplesd | Detected virusese | References | ||
|---|---|---|---|---|---|---|
| Vol. (l) | No. | >0 | ||||
| MgCl2 | Urban wastewater (raw influent, intermediate and final effluents) | 0.1 | 3 | 3 | NoV GI/GII | Tong et al. ( |
| Surface water (freshwater and seawater) | 2.0 | 16 | 13 5/10 | NoV GI/GII NoV GI/NoV GII | ||
| Wastewater (raw sewage influent) | – | 14 | 9 8 8 5/3 | PMMoV, klassevirus, NoV, GII/GIV PMMoV Klassevirus NoV GII/NoV GIV | Han et al. ( | |
| MgCl2 (CU) | Seawaterb (receiving water) | 2.0 | 8 | 3/1 | NV GI/GII | Katayama et al. ( |
| Seawater (bathing beach) | 2.0 | 6 | 4 | EVs | ||
| Wastewater: raw sewage | 0.1 | 17 | 17 | HAdVs | Haramoto et al. ( | |
Secondary-treated sewage Seawaterb | 1.0 | 17 18 | 14 15 | |||
Wastewater: raw influent Secondary-treated effluent | 1.0 0.1 | 72 72 | 72 71 | HAdVs, EVs, NoV GI/GII | Katayama et al. ( | |
| Final effluent | 1.0 | 71 | 68/66 47 71 65/63 41 | HAdVs NoV GI/GII EVs HAdVs NoV GI/GII EVs | ||
Wastewater: raw influent Final effluent | 0.1 1.0 | 12 12 | 12 7 | SaVs | Haramoto et al. ( | |
| Surface (river) water | 2.0 | 52 | 48 | HAV | de Paula et al. ( | |
| Surface (river) water | 2.0 | 52 | 31 23 16 8 3 | RVs, HAdVs, HAstVs, NoVs RVs HAdVs HAstVs NoVs | Miagostovich et al. ( | |
| Wastewater: raw influent | 0.05 | 30 | 30 | HAdVs | Ahmed et al. ( | |
| Primary/secondary effluents | 18/16 | 18/2 | HAdVs, BAdVs | |||
| Septic tanks | 10 | 8 | HAdVs | |||
| Surface (river) water | 0.05 4.0–5.0 | 40 | 8 4 4 | BAdVs | ||
| Seawaterb, brackish water, | 2.0 | 84 | 54/16/7 | HAdVs/RV- | Rigotto et al. | |
wastewater, drinking water Seawater | 36 | 25/13/2 | A/HAV | |||
| Brackish water | 12 | 9/2/2 | ||||
| Wastewater | 12 | 8/1/1 | ||||
| Drinking water | 24 | 12/0/2 | ||||
Wastewater: raw influent Treated effluent | 0.1 1.0 | 24 | 24 | Enteric viruses (10 types)f, PMMoV | Kitajima et al. | |
| MgCl2 (PEGP) | Surface (river) water | 10.0 | 41 | 41 40 40 37 33 13 1 | HAdVs, HPyVs, RV-A, NoV GII, EVs, somatic coliphages HAdVs HPyVs RV-A Somatic coliphages NoV GII EVs | Hamza et al. |
| AlCl3 | Urban surface (river or lake) water | 0.5 | 108 | 58 52 6 5 | RVs, HAstVs, NoVs RVs HAstVs NoVs | He et al. ( |
| AlCl3 (CU) | Tap water | 303 (100–532) | 98 | 10 4/7 | NoV GI/GII NoV GI/NoV GII | Haramoto et al. ( |
| Surface (river) water | 0.5 | 64 | 43 34/28 29 6 3 | NoV GI/GII, HAdVs, EVs, TTVs NoV GI/NoV GII HAdVs EVs TTVs | Haramoto et al. ( | |
| Surface (river) water | 0.5 | 36 | 29 | HAdVs | Haramoto et al. ( | |
| Surface (river) water | 0.5 | 36 60 | 23 12 | SaVs | Haramoto et al. ( Kitajima et al. ( | |
| Wastewater (raw sewage, primary, secondary and final effluents)/combined sewer overflowsc) | 0.1–2.0 | 46/6 26 | 46/6 10 | HAdVs | Fong et al. ( | |
| Surface (river) water | 0.5–2.0 | |||||
| Groundwater (artesian wells) | 0.5 | 202 | 4/1 | NoV/RV | Chironna et al. ( | |
aMgCl2: a solution of MgCl2 was added to the water sample before filtration according to Katayama et al. (2002); AlCl3: a solution of AlCl3 was passed through the filter before water sample filtration, according to Haramoto et al. (2004). Ninety-mm diameter (Ø) filters were used, except in Tong et al. (2011) (Ø = 47 mm), Hamza et al. (2009) and Rigotto et al. (2010) (Ø = 142 mm), and Haramoto et al. (2004) (Ø = 293 mm + Ø = 47 mm). In both methods, filters were rinsed with 0.5 mM H2SO4, pH 3.0 before virus elution using 1 mM NaOH (pH 10.8). In parentheses, secondary concentration step applied: CU, centrifugal ultrafiltration; PEGP, polyethylene glycol precipitation
bNo MgCl2 added
cCombination of storm water and untreated sewage
dThe average volume, total number and number of virus-positive (for at least one virus type in a mixture of viruses or for a given virus type) samples are given
eBAdV, bovine adenovirus; EV (human enterovirus); HAdV, human adenovirus; HPyV, human polyomavirus; HAstV, human astrovirus; HAV, hepatitis A virus; NoV, norovirus; NoV GI/GII/GIV, norovirus genogroup I/II/IV; NV GI/GII, Norwalk virus (norovirus) genogroup I/II; PMMoV, pepper mild mottle virus; RV, rotavirus; RV-A, rotavirus A; SaV, sapovirus (Sapporo-like virus); TTV, torque teno virus
fAiV, (Aichi virus), BKPyV (BK polyomavirus), EVs, HAdVs, JCPyV (JC polyomavirus), NoV GI/GII/GIV, RV-A, SaVs
Fig. 5Relative survivabilitya (RS) of MS2 viruses on filtersb treated with different concentrations of DAS suspension. Error bars (n = 3) are shown. Taken from Woo et al. (2012). aRatio of the virus survival factor in the treated filter to that in the untreated filter, where the virus survival factor in a filter is the number of viruses recovered by elution from the filter divided by the number of viruses removed by the filtration process. b PF PP filter from commercial surgical mask (DuPont™ 01361N), CCF coarse pore cellulose filter paper (Whatman™ Grade 54, 22 μm pore size), FCF fine pore cellulose filter paper (Whatman™ Grade 50, 2.7 μm pore size)